Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Nearby SuDoc Numbers are:
Result Page   Prev Next
Add Marked to Bag Add All On Page
Mark   Media Year
He 20. 4702 :N 42    
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA. HE 20.4702:N 42 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
He 20. 4702 :N 42/ 2    
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, questions and answe HE 20.4702:N 42/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2001
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, questions and answe Axe Federal Documents Online:Available   ElectronicResource GovDoc 2001
He 20. 4702 :N 42/ 3    
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, specifications, use HE 20.4702:N 42/3 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
      Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, specifications, use Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
He 20. 4702 :N 73/ 2    
      Guidance for industry [electronic resource] : S7B nonclinical evaluation of the potential for delayed HE 20.4702:N 73/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : S7B nonclinical evaluation of the potential for delayed Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :N 73/ 3    
      Guideline for the format and content of the nonclinical pharmacology/toxicology section of an applica HE 20.4702:N 73/3 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1987
      Guideline for the format and content of the nonclinical pharmacology/toxicology section of an applica Axe Federal Documents Online:Available   ElectronicResource GovDoc 1987
He 20. 4702 :Or 1    
      Guidance for industry [electronic resource] : extended release oral dosage forms, development, evalua HE 20.4702:OR 1 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1997
      Guidance for industry [electronic resource] : extended release oral dosage forms, development, evalua Axe Federal Documents Online:Available   ElectronicResource GovDoc 1997
He 20. 4702 :Or 3    
      Guidance for industry [electronic resource] : M4, organization of the CTD. HE 20.4702:OR 3 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2001
      Guidance for industry [electronic resource] : M4, organization of the CTD. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2001
He 20. 4702 :Ot 4/Draft    
      Guidance for industry [electronic resource] : acute bacterial otitis media, developing drugs for trea HE 20.4702:OT 4/DRAFT ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Guidance for industry [electronic resource] : acute bacterial otitis media, developing drugs for trea Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :Ou 8    
      Guidance for industry [electronic resource] : investigating out-of-specification test results (OOS) f HE 20.4702:OU 8 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : investigating out-of-specification test results (OOS) f Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 21    
      Guidance for industry [electronic resource] : submission of documentation in applications for paramet HE 20.4702:P 21 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2010
      Guidance for industry [electronic resource] : submission of documentation in applications for paramet Axe Federal Documents Online:Available   ElectronicResource GovDoc 2010
He 20. 4702 :P 27    
      Guidance for industry [electronic resource] : patient-reported outcome measures, use in medical produ HE 20.4702:P 27 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : patient-reported outcome measures, use in medical produ Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 34    
      Guidance for industry [electronic resource] : how to comply with the Pediatric Research Equity Act. HE 20.4702:P 34 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : how to comply with the Pediatric Research Equity Act. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :P 34/ 2    
      Guidance for industry [electronic resource] : qualifying for pediatric exclusivity under section 505A HE 20.4702:P 34/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1999
      Guidance for industry [electronic resource] : qualifying for pediatric exclusivity under section 505A Axe Federal Documents Online:Available   ElectronicResource GovDoc 1999
He 20. 4702 :P 34/ 3    
      Guidance for industry [electronic resource] : nonclinical safety evaluation of pediatric drug product HE 20.4702:P 34/3 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : nonclinical safety evaluation of pediatric drug product Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 49    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/ 2    
      Guidance for industry [electronic resource] : pharmacogenomic data submissions. HE 20.4702:P 49/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : pharmacogenomic data submissions. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :P 49/ 3/Rev. 2    
      Guidance for industry [electronic resource] : Q8(R2) pharmaceutical development. HE 20.4702:P 49/3/REV.2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q8(R2) pharmaceutical development. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/ 4    
      Guidance for industry [electronic resource] : E2E pharmacovigilance planning. HE 20.4702:P 49/4 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : E2E pharmacovigilance planning. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :P 49/ 5    
      Guidance for industry [electronic resource] : good pharmacovigilance practices and pharmacoepidemiolo HE 20.4702:P 49/5 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : good pharmacovigilance practices and pharmacoepidemiolo Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :P 49/ 6    
      Guidance for industry [electronic resource] : PAT, a framework for innovative pharmaceutical developm HE 20.4702:P 49/6 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
      Guidance for industry [electronic resource] : PAT, a framework for innovative pharmaceutical developm Axe Federal Documents Online:Available   ElectronicResource GovDoc 2004
He 20. 4702 :P 49/ 7    
      Guidance for industry [electronic resource] : manufacturing, processing, or holding active pharmaceut HE 20.4702:P 49/7 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1998
      Guidance for industry [electronic resource] : manufacturing, processing, or holding active pharmaceut Axe Federal Documents Online:Available   ElectronicResource GovDoc 1998
He 20. 4702 :P 49/ 8    
      Guidance for industry [electronic resource] : pharmaceutical components at risk for melamine contamin HE 20.4702:P 49/8 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : pharmaceutical components at risk for melamine contamin Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/ 9    
      Guidance for industry [electronic resource] : population pharmacokinetics. HE 20.4702:P 49/9 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1999
      Guidance for industry [electronic resource] : population pharmacokinetics. Axe Federal Documents Online:Available   ElectronicResource GovDoc 1999
He 20. 4702 :P 49/ 10    
      Guidance for industry [electronic resource] : pharmacogenomic data submissions, companion evidence. HE 20.4702:P 49/10 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2007
      Guidance for industry [electronic resource] : pharmacogenomic data submissions, companion evidence. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2007
He 20. 4702 :P 49/ 11    
      Guidance for industry [electronic resource] : photosafety testing. HE 20.4702:P 49/11 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2003
      Guidance for industry [electronic resource] : photosafety testing. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2003
He 20. 4702 :P 49/Annex 1    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49/ANNEX 1 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/Annex 2    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49/ANNEX 2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/Annex 3    
      Guidance for industry : Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH HE 20.4702:P 49/ANNEX 3 ; Axe Federal Documents Online:Available   Electronic Book 2009
      Guidance for industry : Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH Axe Federal Documents Online:Available   Electronic Book 2009
He 20. 4702 :P 49/Annex 4a    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49/ANNEX 4 A ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/Annex 4b    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49/ANNEX 4 B ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/Annex 4c    
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex HE 20.4702:P 49/ANNEX 4 C ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial tex Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 49/Annex 5/Draft    
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 5, Disint HE 20.4702:P 49/ANNEX 5/DRAFT ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 5, Disint Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/Annex 6/Draft    
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 6, Unifor HE 20.4702:P 49/ANNEX 6/DRAFT ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 6, Unifor Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/Annex 7/Draft    
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 7, Dissol HE 20.4702:P 49/ANNEX 7/DRAFT ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 7, Dissol Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/Annex 8/Draft    
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 8, Steril HE 20.4702:P 49/ANNEX 8/DRAFT ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
      Q4B evaluation and recommendation of pharmacopeoial texts for use in the ICH regions. Annex 8, Steril Axe Federal Documents Online:Available   ElectronicResource GovDoc 2008
He 20. 4702 :P 49/Annex 9    
      Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions [electronic reso HE 20.4702:P 49/ANNEX 9 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions [electronic reso Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :P 56    
      Guidance for industry [electronic resource] : Q1B photostability testing of new drug substances and p HE 20.4702:P 56 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1996
      Guidance for industry [electronic resource] : Q1B photostability testing of new drug substances and p Axe Federal Documents Online:Available   ElectronicResource GovDoc 1996
He 20. 4702 :P 76    
      Guidance for industry [electronic resource] : ANDAs, pharmaceutical solid polymorphism, chemistry, ma HE 20.4702:P 76 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2007
      Guidance for industry [electronic resource] : ANDAs, pharmaceutical solid polymorphism, chemistry, ma Axe Federal Documents Online:Available   ElectronicResource GovDoc 2007
He 20. 4702 :P 84    
      Guidance for industry [electronic resource] : reports on the status of postmarketing study commitmen HE 20.4702:P 84 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : reports on the status of postmarketing study commitmen Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 84/ 4    
      Guidance for industry [electronic resource] : potassium chloride modified-release tablets and capsule HE 20.4702:P 84/4 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : potassium chloride modified-release tablets and capsule Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :P 87/Rev.Attach.      
      Guidance for industry : powder blends and finished dosage units : stratified in-process dosage unit s HE 20.4702:P 87/REV.ATTACH. ; Axe Federal Documents Online:Available   Electronic Book 2003
He 20. 4702 :P 87rev.Attach.      
      Guidance for industry : powder blends and finished dosage units : stratified in-process dosage unit s Axe Federal Documents Online:Available   Electronic Book 2003
He 20. 4702 :P 92    
      Guidance for industry [electronic resource] : Prescription Drug Marketing Act, donation of prescripti HE 20.4702:P 92 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : Prescription Drug Marketing Act, donation of prescripti Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 92/ 2    
      Guidance for industry [electronic resource] : Prescription Drug Marketing Act (PDMA) requirements, qu HE 20.4702:P 92/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : Prescription Drug Marketing Act (PDMA) requirements, qu Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :P 92/ 3    
      Guidance for industry and review staff [electronic resource] : labeling for human prescription drug a HE 20.4702:P 92/3 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry and review staff [electronic resource] : labeling for human prescription drug a Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :Q 1    
      Guidance for industry [electronic resource] : Q9 quality risk management. HE 20.4702:Q 1 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : Q9 quality risk management. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :Q 1/ 2    
      Guidance for industry [electronic resource] : quality systems approach to pharmaceutical CGMP regulat HE 20.4702:Q 1/2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
      Guidance for industry [electronic resource] : quality systems approach to pharmaceutical CGMP regulat Axe Federal Documents Online:Available   ElectronicResource GovDoc 2006
He 20. 4702 :Q 2    
      Guidance for industry [electronic resource] : Q10 pharmaceutical quality system. HE 20.4702:Q 2 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
      Guidance for industry [electronic resource] : Q10 pharmaceutical quality system. Axe Federal Documents Online:Available   ElectronicResource GovDoc 2009
He 20. 4702 :R 11    
      Guidance for industry [electronic resource] : collection of race and ethnicity data in clinical trial HE 20.4702:R 11 ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
      Guidance for industry [electronic resource] : collection of race and ethnicity data in clinical trial Axe Federal Documents Online:Available   ElectronicResource GovDoc 2005
He 20. 4702 :R 26/ 2/    
      Quick index to general subjects of interest related to drug regulation [electronic resource]. HE 20.4702:R 26/2/ ; Axe Federal Documents Online:Available   ElectronicResource GovDoc 1992
      Quick index to general subjects of interest related to drug regulation [electronic resource]. Axe Federal Documents Online:Available   ElectronicResource GovDoc 1992
Add Marked to Bag Add All On Page
Result Page   Prev Next
 
    
Available items only